ERBB2 and triple-negative breast carcinoma: Furthermore, 70% of BRCA1-associated breast cancers are triple-negative breast cancer (TNBC): estrogen receptor (ER)-, progesterone receptor (PR)-, and HER2-negative cancers [7].